Lentiviral-mediated targeted NF-κB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat
Lentiviral-mediated targeted NF-κB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat
复制标题
DOI:
10.1038/sj.mt.6300107
复制
发表时间:
2007-04-01
影响因子:
12.4
通讯作者:
Pohl, Michel
中科院分区:
文献类型:
--
作者:
Meunier, Alice;Latremoliere, Alban;Pohl, Michel
Neuropathic pain developing after peripheral nerve injury is associated with altered neuronal and glial cell functions in the spinal cord. Activated glia produces algogenic mediators, exacerbating pain. Among the different intracellular pathways possibly involved in the modified glial function, the nuclear factor kappa B (NF-kappa B) system is of particular interest, as numerous genes encoding inflammation- and pain-related molecules are controlled by this transcription factor. NF-kappa B is a pleiotropic factor also involved in central nervous system homeostasy. To study its role in chronic pain, it is thus essential to inhibit the NF-kappa B pathway selectively in activated spinal glial cells. Here, we show that when restricted to spinal cord and targeted to glial cells, lentiviral vector-mediated delivery of NF-kappa B superrepressor I kappa B alpha resulted in an inhibition of the NF-kappa B pathway activated in the rat spinal cord after sciatic nerve injury (chronic constriction injury, CCI). Concomitantly, I kappa B alpha overproduction prevented the enhanced expression of interleukin-6 and of inducible nitric oxide synthase associated with chronic constriction injury and resulted in prolonged antihyperalgesic and antiallodynic effects. These data show that targeted blockade of NF-kappa B activity in spinal glia efficiently alleviates pain behavior in CCl rats, demonstrating the active participation of the glial NF-kappa B pathway in the development of neuropathic pain after peripheral nerve injury.